D2 partial agonists for relapse prevention in schizophrenia - the long-term view

被引：0
|
作者：
Correll, C. U. [1 ,2 ]
机构：
[1] Zucker Hillside Hosp, Hofstra North Shore LIJ Sch Med, Psychiat, Glen Oaks, NY USA
[2] Zucker Hillside Hosp, Recognit & Prevent Program, Glen Oaks, NY USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2019年 / 29卷
关键词：
ARIPIPRAZOLE;
D O I：
10.1016/j.euroneuro.2018.11.998
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
C.13.05
引用
收藏
页码：S630 / S630
页数：1
相关论文
共 50 条
  • [1] Novel dopamine D2 partial agonists in the treatment of schizophrenia
    Correll, C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S668 - S668
  • [2] D2 partial agonists: their pharmacology and potential role in schizophrenia
    Agid, O.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S1137 - S1138
  • [3] Towards consensus in the long-term management of relapse prevention in schizophrenia
    Taylor, M
    Chaudhry, I
    Cross, M
    McDonald, E
    Miller, P
    Pilowsky, L
    Strickland, P
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2005, 20 (03) : 175 - 181
  • [4] Efficacy and safety of D2 partial agonists in the treatment of schizophrenia - the short-term perspective
    Mattingly, G.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S629 - S630
  • [5] Comparative Tolerability of Dopamine D2/3 Receptor Partial Agonists for Schizophrenia
    Keks, Nicholas
    Hope, Judith
    Schwartz, Darren
    McLennan, Harold
    Copolov, David
    Meadows, Graham
    [J]. CNS DRUGS, 2020, 34 (05) : 473 - 507
  • [6] Comparative Tolerability of Dopamine D2/3 Receptor Partial Agonists for Schizophrenia
    Nicholas Keks
    Judith Hope
    Darren Schwartz
    Harold McLennan
    David Copolov
    Graham Meadows
    [J]. CNS Drugs, 2020, 34 : 473 - 507
  • [7] From antipsychotic to D2 antagonists and D2 partial agonists
    Stahl, S.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S152 - S152
  • [8] Developing New Dopamine D2 Receptor Agonists and Partial Agonists for Parkinson's Disease and Schizophrenia
    Keck, Thomas
    Nguyen, Catherine
    Kurtyan, Emily
    Stephanie, Bohn
    Crowthers, Raymond
    Tharakan, Jaslin
    Briaguez, Wendy
    Ricchezza, Joseph
    Pino, Michael
    Brunt, Dylan
    Sullivan, Holli-Joi
    Wu, Chun
    [J]. FASEB JOURNAL, 2020, 34
  • [9] Long-term stability of measuring D2 receptors in schizophrenia patients treated with antipsychotics
    Uchida, Hiroyuki
    Graff-Guerrero, Ariel
    Mulsant, Benoit H.
    Pollock, Bruce G.
    Mamo, David C.
    [J]. SCHIZOPHRENIA RESEARCH, 2009, 109 (1-3) : 130 - 133
  • [10] Atomoxetine in the long-term prevention of relapse in ADHD
    Michelson, D
    Buitelaar, JK
    Danckaerts, M
    Gillberg, C
    Spencer, TJ
    Zuddas, A
    Zhang, S
    Biederman, J
    [J]. EUROPEAN PSYCHIATRY, 2004, 19 : 240S - 240S
12345